| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/20/2007 | CN1984885A Bicyclic aromatic sulfinyl derivatives |
| 06/20/2007 | CN1984681A Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 06/20/2007 | CN1981837A Chinese-medicinal composition for adjusting human-body viscera function |
| 06/20/2007 | CN1981776A Composition containing rare ginseng saponin, its production and usage |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981742A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/20/2007 | CN1981739A Esmolol preparation |
| 06/20/2007 | CN1981624A Cereals gruel with equilibrium nutrients during growth development period for youth |
| 06/20/2007 | CN1322121C Hyaluronan synthase gene and uses thereof |
| 06/20/2007 | CN1322001C Novel compounds that inhibit factor Xa activity |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321687C Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321667C Capsule sheep extractive for protecting, strengthening health and preserving youth |
| 06/20/2007 | CN1321666C Combination of medication of containing astragalus root and dragon's blood resin and application |
| 06/20/2007 | CN1321641C Method for treating allergies using substituted pyrazoles |
| 06/20/2007 | CN1321635C Binding partners for 5-HT5 receptors for treatment of migraine |
| 06/19/2007 | US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232904 Crystal of arylethenesulfonamide derivative and preparation process thereof |
| 06/19/2007 | US7232879 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 06/19/2007 | US7232846 endogenic polyamines (putrescine, spermidine, spermine), 1,3-propanediamine, their salts and solvates, bioprecursor amides for therapeutical and prophylactic treatment of alcoholism in a human |
| 06/19/2007 | US7232838 2-amino-4,5-trisubstituted thiazolyl derivatives |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 06/19/2007 | US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | US7232690 Adding a target to mixture and forming a complex of target and at least one active chemical substance of the mixture,separating the complex from the inactive chemical substances of the mixture, andeitherliberating and isolating and/or identifying at least one active chemical substance |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 06/19/2007 | CA2195127C Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 06/19/2007 | CA2166179C Use of a tnf-alpha antagonist in a cosmetic, pharmaceutical or skincare composition and composition thus obtained |
| 06/19/2007 | CA2158745C Inhibitor of vascular endothelial cell growth factor |
| 06/14/2007 | WO2007066781A1 Process for producing pharmaceutical composition containing drug-encapsulating polymer micelle using fluorine-containing organic solvent |
| 06/14/2007 | WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007066041A2 Skin depigmentation composition containing a naphthonic acid derivative |
| 06/14/2007 | WO2007044560A3 Modulators of atp-binding cassette transporters |
| 06/14/2007 | WO2007012962A3 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070135625 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 06/14/2007 | US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135486 antidiabetic drugs or foods; sulfonium compounds |
| 06/14/2007 | US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135447 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 06/14/2007 | US20070135444 Treatment of neuroblastoma |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070135414 Tachykinin Antagonists |
| 06/14/2007 | US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 06/14/2007 | US20070135404 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135366 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 06/14/2007 | US20070135354 Hematopoietic stimulation |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135346 Prodrugs of CC-1065 analogs |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070135336 Follistatin isoforms and uses thereof |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134646 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134198 Composition and use of RAR antagonists for promoting chondrogenesis |
| 06/14/2007 | US20070134193 Cosmetic and/or pharmaceutical preparations |
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795206A1 Drug for treating or preventing hcv infection |
| 06/13/2007 | EP1795194A2 Use of an antagonist of CB1 receivers associated with a beta3-agonist for preparing medication to be used for treating appetence |
| 06/13/2007 | EP1793832A2 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/13/2007 | EP1793818A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 06/13/2007 | EP1793671A2 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1437353B1 Alkyl ether derivatives or salts thereof |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 06/13/2007 | EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 06/13/2007 | EP1230265B1 Ctage gene family |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1117804B1 Mutants of op-1 |
| 06/13/2007 | EP1083177B1 Compounds capable of cleaving double-stranded dna and method of utilization of the same |
| 06/13/2007 | EP1012304B1 Component of bromelain |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | EP0986572B2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 06/13/2007 | EP0975354B1 Ligand/lytic peptide compositions and methods of use |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | CN1980664A CRTH2 receptor ligands for therapeutic use |
| 06/13/2007 | CN1978463A Mesenchymal stem cell affinity peptide screening and use |
| 06/13/2007 | CN1978456A Human hNit3-ase gene sequence, and its coded protein and preparing method |